Page last updated: 2024-11-05

ticlopidine and Extramembranous Glomerulopathy

ticlopidine has been researched along with Extramembranous Glomerulopathy in 3 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SH1
Cho, YJ1
Kim, YL1
Kwak, JS1
Kim, YJ1
Cho, DK1
Tholl, U1
Anlauf, M1
Helmchen, U1
Yamada, T1
Tomioka, K1
Horie, M1
Sakurai, Y1
Nagaoka, H1
Mase, T1

Other Studies

3 other studies available for ticlopidine and Extramembranous Glomerulopathy

ArticleYear
Clopidogrel-induced membranous nephropathy.
    Clinical nephrology, 2003, Volume: 60, Issue:3

    Topics: Aged; Clopidogrel; Glomerulonephritis, Membranous; Humans; Male; Platelet Aggregation Inhibitors; Ti

2003
Clopidogrel and membranous nephropathy.
    Lancet (London, England), 1999, Oct-23, Volume: 354, Issue:9188

    Topics: Clopidogrel; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Platelet Aggregation Inhibit

1999
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
    Biochemical and biophysical research communications, 1991, Apr-30, Volume: 176, Issue:2

    Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Mal

1991